Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: the Danish experience

被引:26
作者
Iversen, L. H. [1 ]
Rasmussen, P. C. [1 ]
Hagemann-Madsen, R. [2 ]
Laurberg, S. [1 ]
机构
[1] Aarhus Univ Hosp THG, Dept Surg, DK-8000 Aarhus, Denmark
[2] Aarhus Univ Hosp THG, Dept Pathol, DK-8000 Aarhus, Denmark
关键词
Cytoreductive surgery; HIPEC; peritoneal carcinomatosis; pseudomyxoma peritonei; survival; treatment outcome; LONG-TERM SURVIVAL; PSEUDOMYXOMA PERITONEI; SYSTEMIC CHEMOTHERAPY; APPENDICEAL ORIGIN; HIPEC;
D O I
10.1111/codi.12185
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aim Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) is a treatment option with curative intent for selected patients with peritoneal carcinomatosis (PC). CRS and HIPEC have been implemented in Denmark at a single centre since 2006. Six years of data on these patients were analysed. Method Patients with PC from colorectal or appendiceal cancer, pseudomyxoma peritonei or malignant peritoneal mesothelioma referred to the single national HIPEC centre were prospectively registered from June 2006 to July 2012. Morbidity, 30-day mortality and long-term survival of patients who underwent CRS and HIPEC were analysed. Results In total, 80 patients underwent CRS and HIPEC. PC originated from colorectal cancer in 34 patients, pseudomyxoma peritonei in 29, appendiceal cancer in 13 and malignant peritoneal mesothelioma in four patients. Thirty-two patients had one or more complications during the hospital stay. The 30-day mortality rate was 1.3%. The predicted 2-, 3- and 5-year survival was 60%, 47% and 38% in patients with PC from colorectal cancer, and 100%, 93% and 73% in pseudomyxoma peritonei patients. Conclusion CRS and HIPEC is a safe procedure when centralized as in Denmark. Favourable long-term outcome was achieved in selected patients with PC from colorectal cancer and pseudomyxoma peritonei. Shortterm and long-term outcomes were comparable to results from international centres.
引用
收藏
页码:E365 / E372
页数:8
相关论文
共 23 条
  • [1] A Systematic Review and Meta-Analysis of Cytoreductive Surgery with Perioperative Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Origin
    Cao, Christopher
    Yan, Tristan D.
    Black, Deborah
    Morris, David L.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (08) : 2152 - 2165
  • [2] Carr NJ., 2010, WHO CLASSIFICATION T, P122
  • [3] Pathology and prognosis in pseudomyxoma peritonei: a review of 274 cases
    Carr, Norman J.
    Finch, Jenny
    Ilesley, Ian Charles
    Chandrakumaran, Kandiah
    Mohamed, Faheez
    Mirnezami, Alex
    Cecil, Tom
    Moran, Brendan
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2012, 65 (10) : 919 - 923
  • [4] Multi-institutional experience of diffuse intra-abdominal multicystic peritoneal mesothelioma
    Chua, T. C.
    Yan, T. D.
    Deraco, M.
    Glehen, O.
    Moran, B. J.
    Sugarbaker, P. H.
    [J]. BRITISH JOURNAL OF SURGERY, 2011, 98 (01) : 60 - 64
  • [5] Early- and Long-Term Outcome Data of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
    Chua, Terence C.
    Moran, Brendan J.
    Sugarbaker, Paul H.
    Levine, Edward A.
    Glehen, Olivier
    Gilly, Francois N.
    Baratti, Dario
    Deraco, Marcello
    Elias, Dominique
    Sardi, Armando
    Liauw, Winston
    Yan, Tristan D.
    Barrios, Pedro
    Gomez Portilla, Alberto
    de Hingh, Ignace H. J. T.
    Ceelen, Wim P.
    Pelz, Joerg O.
    Piso, Pompiliu
    Gonzalez-Moreno, Santiago
    Van der Speeten, Kurt
    Morris, David L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (20) : 2449 - 2456
  • [6] Peritoneal pseudomyxoma:: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
    Elias, D.
    Honore, C.
    Ciuchendea, R.
    Billard, V.
    Raynard, B.
    Lo Dico, R.
    Dromain, C.
    Duvillard, P.
    Goere, D.
    [J]. BRITISH JOURNAL OF SURGERY, 2008, 95 (09) : 1164 - 1171
  • [7] Complete Cytoreductive Surgery Plus Intraperitoneal Chemohyperthermia With Oxaliplatin for Peritoneal Carcinomatosis of Colorectal Origin
    Elias, Dominique
    Lefevre, Jeremie H.
    Chevalier, Julie
    Brouquet, Antoine
    Marchal, Frederic
    Classe, Jean-Marc
    Ferron, Gwenael
    Guilloit, Jean-Marc
    Meeus, Pierre
    Goere, Diane
    Bonastre, Julia
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (05) : 681 - 685
  • [8] Quantitative prognostic indices in peritoneal carcinornatosis
    Gilly, F. N.
    Cotte, E.
    Brigand, C.
    Monneuse, O.
    Beaujard, A. C.
    Freyer, G.
    Glehen, O.
    [J]. EJSO, 2006, 32 (06): : 597 - 601
  • [9] The Treatment of Peritoneal Carcinomatosis of Colorectal Cancer with Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Peroperative Chemotherapy (HIPEC) with Oxaliplatin: A Belgian Multicentre Prospective Phase II Clinical Study
    Hompes, Daphne
    D'Hoore, Andre
    Van Cutsem, Eric
    Fieuws, Steffen
    Ceelen, Wim
    Peeters, Marc
    Van der Speeten, Kurt
    Bertrand, Claude
    Legendre, Hugues
    Kerger, Joseph
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (07) : 2186 - 2194
  • [10] Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis
    Iversen, L. H.
    Rasmussen, P. C.
    Laurberg, S.
    [J]. BRITISH JOURNAL OF SURGERY, 2013, 100 (02) : 285 - 292